-
-
APPG on ABI launches report on acquired brain injury and neurorehabilitation
-
12th Oct 2018
-
Posted in Industry News,Rehabilitation Articles
- APPG on ABI launches report on acquired brain injury and neurorehabilitation
-
-
New clinical practice data confirms clinical effectiveness of Zebinix® (eslicarbazepine acetate) monotherapy for focal-onset epilepsy in adults
-
8th Oct 2018
-
Posted in Industry News
- New clinical practice data on Zebinix® (eslicarbazepine acetate) monotherapy for focal-onset epilepsy in adults
-
-
Spinraza® ▼ (nusinersen) Interim Data demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy
-
8th Oct 2018
-
Posted in Industry News
- Spinraza® ▼ (nusinersen) Interim Data from Phase 2 Trial, NURTURE, Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic...
-
-
Complex Epilepsy Study Day
-
3rd Oct 2018
-
Posted in Courses & Conferences
- Your invitation to find out more about managing complex epilepsy
-
-
Live online talk this Monday with Professor Gavin Giovannoni – for MS Specialists
-
21st Sep 2018
-
Posted in Courses & Conferences
- Don't miss Monday's online talk - register now, spaces limited
-
-
Why patients should be able to request an Upright Open MRI scan
-
16th Sep 2018
-
Posted in Industry News
- Industry News from Medserena
-
-
Be part of the change: put an end to MS service variance
-
7th Sep 2018
-
Posted in Courses & Conferences
- More information about a new fully funded national meeting on 1st and 2nd November in Birmingham - from the Neurology Academy
-
-
GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology
-
28th Aug 2018
-
Posted in Industry News,Neurology News
- News from GW Pharma
-
-
NICE dementia guideline/guidance updated
-
12th Aug 2018
-
Posted in Clinical Review Article
- Andrew Larner
-
-
9th Aug 2018
-
Posted in Courses & Conferences
- Course starts 8th November, 2018